The high expression of UBQLN2 contributed nearly 100 points to the total points, which was higher than those contributed by the age and pTNM stage, suggesting that UBQLN2 played a more important role in the prognosis of patients with ESCC than other risk factors. The gene discussed is UBQLN2; the disease is esophageal squamous cell carcinoma.